Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05465538 · ClinicalTrials.gov registry record · Phase 1
SV2A in Older Adults
A Phase 1 study of Cannabis Use, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05465538: Recruiting Phase 1 study of Cannabis Use, sponsored by Yale University.
NCT05465538 is a Phase 1 study of Cannabis Use that is actively recruiting participants, run by Yale University. The registered enrollment target is 24 participants, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05465538, a Phase 1 study of Cannabis Use, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.
Primary Outcome
Measure of synaptic density in the hippocampus
Conditions Studied
Interventions
- DRUG [11C]UCB-J PET
Study Locations (1)
Connecticut
- Conneticut Mental Health Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2027-09-30 |
| Phase | Phase 1 |
What NCT05465538 shows while recruiting
NCT05465538 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which [11C]UCB-J PET is the first listed.
NCT05465538 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05465538 about?
NCT05465538 is a clinical study titled "SV2A in Older Adults". The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.
What is the current status of trial NCT05465538?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-07-06. Estimated completion is 2027-09-30.
What conditions does trial NCT05465538 study?
This clinical trial studies the following conditions: Cannabis Use.
What interventions are being tested in trial NCT05465538?
The interventions under investigation include: [11C]UCB-J PET (DRUG).
Who is sponsoring clinical trial NCT05465538?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05465538 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05465538's enrollment target sits among peer trials
24 41st of 44 higher than 4 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
RECRUITING · Phase 1
-
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI